Because of the excellent capacity of stem cell-derived Treg cells in suppression of autoimmunity (62), generation of antigen-specific Foxp3+ Treg cells from stem cells such as iPSCs and HSCs may open a new area in Treg cell-based immunotherapy in transplantation and autoimmune disorders. Here, FOXP3 is linked to autoimmune disease.